A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre-Post Study.
| Autor: | Ang IYH; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore., Tan KXQ; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; NOVI Health, Singapore, Singapore., Tan C; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Singapore Armed Forces, Singapore, Singapore., Tan CH; Singapore Armed Forces, Singapore, Singapore., Kwek JWM; Singapore Armed Forces, Singapore, Singapore., Tay J; NOVI Health, Singapore, Singapore., Toh SA; NOVI Health, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore.; Regional Health System Office, National University Health System, Singapore, Singapore. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JMIR diabetes [JMIR Diabetes] 2021 Jul 09; Vol. 6 (3), pp. e25820. Date of Electronic Publication: 2021 Jul 09. |
| DOI: | 10.2196/25820 |
| Abstrakt: | Background: With increasing type 2 diabetes prevalence, there is a need for effective programs that support diabetes management and improve type 2 diabetes outcomes. Mobile health (mHealth) interventions have shown promising results. With advances in wearable sensors and improved integration, mHealth programs could become more accessible and personalized. Objective: The study aimed to evaluate the feasibility, acceptability, and effectiveness of a personalized mHealth-anchored intervention program in improving glycemic control and enhancing care experience in diabetes management. The program was coincidentally implemented during the national-level lockdown for COVID-19 in Singapore, allowing for a timely study of the use of mHealth for chronic disease management. Methods: Patients with type 2 diabetes or prediabetes were enrolled from the Singapore Armed Forces and offered a 3-month intervention program in addition to the usual care they received. The program was standardized to include (1) in-person initial consultation with a clinical dietitian; (2) in-person review with a diabetes specialist doctor; (3) 1 continuous glucose monitoring device; (4) access to the mobile app for dietary intake and physical activity tracking, and communication via messaging with the dietitian and doctor; and (5) context-sensitive digital health coaching over the mobile app. Medical support was rendered to the patients on an as-needed basis when they required advice on adjustment of medications. Measurements of weight, height, and glycated hemoglobin A Results: Over a 4-week recruitment period, 130 individuals were screened, the enrollment target of 30 patients was met, and 21 patients completed the program and were included in the final analyses; 9 patients were lost to follow-up (full data were not available for the final analyses). There were no differences in the baseline characteristics between patients who were included and excluded from the final analyses (age category: P=.23; gender: P=.21; ethnicity: P>.99; diabetes status category: P=.52, medication adjustment category: P=.65; HbA Conclusions: The personalized mHealth program was feasible, acceptable, and produced significant reductions in HbA (©Ian Yi Han Ang, Kyle Xin Quan Tan, Clive Tan, Chiew Hoon Tan, James Wei Ming Kwek, Joanne Tay, Sue Anne Toh. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 09.07.2021.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|